Featured Events
This special session organized by the ASHG President addresses a topic the President finds particularly relevant, pressing, or novel in the human genetics and genomics research community.
Moderator
![Bruce D. Gelb, MD, Dean for Child Health Research, Gogel Family Chair and Director of The Mindich Child Health and Development Institute, Director of the Center for Molecular Cardiology, and Professor of Pediatrics and Genetics and Genomic Sciences at Icahn School of Medicine at Mount Sinai](https://www.ashg.org/wp-content/uploads/2024/05/Headshot-2016-Bruce-Gelb-232w.png)
Dean for Child Health Research, Gogel Family Chair and Director of The Mindich Child Health and Development Institute, Director of the Center for Molecular Cardiology, and Professor of Pediatrics and Genetics and Genomic Sciences at Icahn School of Medicine at Mount Sinai
Speakers
![Gregory Radick, PhD, Professor, University of Leeds](https://www.ashg.org/wp-content/uploads/2024/05/Headshot-2024-Gregory-Radick.png)
Professor, University of Leeds
![Athena Starlard-Davenport, PhD, Associate Professor, University of Tennessee Health Science Center](https://www.ashg.org/wp-content/uploads/2024/05/Headshot-2024-Athena-Starlard-Davenport.png)
Associate Professor, University of Tennessee Health Science Center
![Stanislav Y. Shvartsman, PhD, Professor, Princeton University](https://www.ashg.org/wp-content/uploads/2024/05/Headshot-2024-Stanislav-Y-Shvartsman.png)
Professor, Princeton University
This special session, organized by the Program Committee, closes the Annual Meeting by featuring leaders in the human genetics and genomics community in a series of exciting talks related to the future of human genetics followed by Q&A.
The Promise and Payoff of Human Genetics and Genomics: Paths from Bench to Bedside
A major goal of human genetics and genomics research is to understand, treat, and correct genetic diseases and alleviate patient suffering. However, moving discoveries from the bench to the bedside can be both daunting and lengthy. The 2024 Distinguished Speakers Symposium will feature leaders who have made important basic science discoveries and navigated the journey from discovery to drug development, clinical trials, and implementation of new therapies. Their work has given hope to patients and framed the ethics, policy, and communication around ground-breaking genetics and genomics research.
Moderators:
![Gillian Hooker, PhD, ScM, Chief Scientific Officer, Concert and Adjunct Associate Professor, Vanderbilt University Medical Center](https://www.ashg.org/wp-content/uploads/2024/05/Headshot-2024-Gillian-Hooker.png)
Chief Scientific Officer, Concert and Adjunct Associate Professor, Vanderbilt University Medical Center
![Lizeth Tamayo, PhD, Scientist, Tempus AI](https://www.ashg.org/wp-content/uploads/2024/05/Headshot-2024-Lizeth-Tamayo.png)
Scientist, Tempus AI
Speakers
![Crystal Y. Lumpkins](https://www.ashg.org/wp-content/uploads/2024/05/Headshot-2024-Crystal-Y-Lumpkins.png)
Associate Professor, Huntsman Cancer Institute
![David Goldstein, PhD, CEO](https://www.ashg.org/wp-content/uploads/2024/05/Headshot-2024-David-Goldstein.png)
CEO, Actio Biosciences, Inc.
![Heather Hampel, MS, CGC](https://www.ashg.org/wp-content/uploads/2024/05/Headshot-2024-Heather-Hampel.png)
Associate Director, Division of Clinical Cancer Genomics, City of Hope National Medical Center
![David Altshuler, MD, PhD, EVP](https://www.ashg.org/wp-content/uploads/2024/05/Headshot-2024-David-Altshuler.png)
EVP, Global Research and Chief Scientific Officer, Vertex Pharmaceuticals, Inc.
For more information on our session participants, read their biographies.